Home › Cancer (all types) › Vermont › Burlington
Cancer (all types) clinical trials in Burlington, VT
5 studies for Cancer (all types) are looking for participants at sites in and around Burlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- The University of Vermont Medical Center Inc., Burlington
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Vermont and State Agricultural College, Burlington
Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer
Recruiting
- University of Vermont Cancer Center, Burlington
DOAC - Dosing Options in AntiCoagulation Prophylaxis
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- University of Vermont Medical Center, Burlington
- University of Vermount and Sate Agricultural College, Burlington
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX124 studies
- New York City, NY105 studies
- Boston, MA90 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Durham, NC61 studies
- Washington, DC60 studies
- Philadelphia, PA57 studies
- Arlington, VA52 studies
- Chicago, IL51 studies
- St. Louis, MO51 studies
- Atlanta, GA49 studies
Other studies in Burlington
- Acute Myeloid Leukemia7 studies
- Heart Failure7 studies
- COPD5 studies
- Leukemia5 studies
- Breast Cancer4 studies
- Metastatic Cancer4 studies
- Lung Diseases4 studies
- Non-Small Cell Lung Cancer4 studies
- Parkinson's Disease4 studies
- Cystic Fibrosis4 studies
- Cardiovascular Disease4 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.